1
/
of
0
FDA Drug/Biologics Approval BLA 125409 S-109, PERTUZUMAB
FDA Drug/Biologics Approval BLA 125409 S-109, PERTUZUMAB
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 125409 S-109
Company: GENENTECH
Drug Name: PERJETA
Active Ingredients: PERTUZUMAB
Strength: 420MG/14ML
Dosage Form/Route: VIAL; SINGLE-USE
Action Date: 06/08/2012
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: GENENTECH
Drug Name: PERJETA
Active Ingredients: PERTUZUMAB
Strength: 420MG/14ML
Dosage Form/Route: VIAL; SINGLE-USE
Action Date: 06/08/2012
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details